Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.

By G. Clifford, Silvia Franceschi, Mireia Díaz, N. Muñoz, Luisa Lina Villa. Vaccine, 2006

661 citations recorded by the source corpus.

Subfields: Epidemiology, Microbiology, Surgery

View Paper: https://www.semanticscholar.org/paper/dbc0d6a5e420c2c36a4715e569d5ca38a2e9c9b0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. F. Bray
2. J. Ferlay
3. Luisa Lina Villa
4. X. Castellsagué
5. L. Koutsky
6. S. Kjaer
7. M. Arbyn
8. M. Stanley

In Surgery

1. J. Ferlay
2. Luisa Lina Villa
3. F. Bray
4. S. Kjaer
5. M. Stanley

Citations in the corpus

• Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. (2010, background): “For example, of the approximately 26 HPV types that were not tested for, some, such as HPV53 and HPV66, are found in 9%–10% of low-grade squamous intraepithelial lesions (32).”
• Worldwide burden of cervical cancer in 2008. (2011, background): “Additionally, there are two HPV vaccines available that can prevent human papillomavirus type 16 and human papillomavirus type 18 infections, which jointly cause 70%–75% of all cervical cancers and 40%–60% of its precursors [6, 7].”